Thrombosis
Conference Coverage
Oral anticoagulation ‘reasonable’ in advanced kidney disease with A-fib
Reduced stroke risk, no increase in bleeding in atrial fibrillation and advanced chronic kidney disease.
From the Journals
Dabigatran, rivaroxaban linked to slight increase in GI bleeding risk
Overall, the risk of major bleeds associated with NOACs was similar to the risk with conventional anticoagulants.
Conference Coverage
DETOUR system shows early promise for long SFA lesions
Percutaneous treatment of long SFA lesions showed good patency, low rate of major adverse events.
Conference Coverage
IN.PACT Global: Promising 2-year data for drug-coated balloon performance for femoropopliteal PAD
Drug-coated balloon shows promising 2-year results for treating fempop PAD.
Conference Coverage
VIDEO: Educational intervention boosts A fib anticoagulation
BARCELONA – Patient education and feedback increased anticoagulation and cut strokes.
Feature
Absorb bioresorbable scaffold folds
Abbott is no longer marketing the Absorb bioresorbable scaffold, citing poor sales.
Conference Coverage
VIDEO: Clopidogrel bests ticagrelor in PCI for ACS in real-world study
BARCELONA – Fewer adverse events seen with less potent platelet inhibition in contemporary practice in CHANGE DAPT.
Conference Coverage
VIDEO: Rivaroxaban plus aspirin cut cardiovascular events in stable patients
BARCELONA – The COMPASS trial produced “unambiguous results that should change guidelines and the management of stable coronary artery disease,”...
Conference Coverage
CANTOS sings of novel strategy for cardiovascular, cancer prevention
BARCELONA – Targeted anti-inflammatory therapy with canakinumab showed diverse clinical benefits.
Conference Coverage
VIDEO: Inflammation’s role in atherosclerosis confirmed in CANTOS
BARCELONA – Inflammation as a treatment target is definitively shown in the CANTOS trial.
Conference Coverage
Undiagnosed AF common in higher-risk patients
Patients at high risk of atrial fib and stroke commonly have undiagnosed AF.